Related references
Note: Only part of the references are listed.Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels
Byambaa Enkhmaa et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Lipoprotein(a): resurrected by genetics
F. Kronenberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study
Kishor M. Wasan et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
Konstantinos A. Toulis et al.
HUMAN REPRODUCTION UPDATE (2011)
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians
Byambaa Enkhmaa et al.
TRANSLATIONAL RESEARCH (2011)
Association of Lp-PLA2 activity with allele-specific Lp(a) levels in a bi-ethnic population
Byambaa Enkhmaa et al.
ATHEROSCLEROSIS (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Robert A. Wild et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Apolipoprotein(a) Isoforms and the Risk of Vascular Disease Systematic Review of 40 Studies Involving 58,000 Participants
Sebhat Erqou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effects of either Tibolone or Continuous Combined Transdermal Estradiol with Medroxyprogesterone Acetate on Coagulatory Factors and Lipoprotein(a) in Menopause
G. Perrone et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2009)
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype
Manfredi Rizzo et al.
HUMAN REPRODUCTION (2009)
Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
K. Berneis et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Pia R. Kamstrup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population
Pia R. Kamstrup et al.
CIRCULATION (2008)
High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans
Erdembileg Anuurad et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events
Jacqueline Suk Danik et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome
Yilmaz Sahin et al.
CLINICAL ENDOCRINOLOGY (2007)
Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome
Mithat Bahceci et al.
FERTILITY AND STERILITY (2007)
Serum lipoprotein(a) dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women
M. Ushioda et al.
HORMONE AND METABOLIC RESEARCH (2006)
Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women
S. R. Salpeter et al.
DIABETES OBESITY & METABOLISM (2006)
Levels of lipoprotein and homocysteine in non-obese and obese patients with polylcystic ovary syndrome
M Yilmaz et al.
GYNECOLOGICAL ENDOCRINOLOGY (2005)
Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67)
AI Adler et al.
DIABETIC MEDICINE (2005)
High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men
F Paultre et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Evaluation of a new Apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a)
T Dembinski et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)